Marie Thibault

Brooks O'Neil

Jason Wittes

Young Li

- Accuray has appointed **Steve La Neve as Chief Executive Officer**, effective **October 20, 2025**, succeeding Suzanne Winter, as part of a significant organizational, strategic, and operational transformation.  **[1138723_20251020SF01647:0]** 
- **Steven F. Mayer** has been appointed **Transformation Board Sponsor** to oversee the execution of the company's initiatives, with **Chan W. Galbato nominated to the Board of Directors**.  **[1138723_20251020SF01647:1]** 
- The company aims to achieve a **high single-digit adjusted EBITDA margin run-rate within twelve months**, expanding to double digits over the medium to long term.  **[1138723_20251020SF01647:1]** 
- For its fiscal 2026 first quarter, Accuray expects preliminary total revenues of **$92.5 to $94 million** and adjusted EBITDA of approximately **($4) million**.  **[1138723_20251020SF01647:1]**

Accuray Announces Leadership Changes and Transformation Plan

- Accuray announced that **5D Clinics** has treated the **first patients in Melbourne, Australia**, using the **CyberKnife S7™ System**.  **[1138723_20251008SF92852:0]** 
- This milestone is part of a **joint venture between 5D Clinics and Icon Group** to open and operate CyberKnife System centers across Australia, aiming to increase access to precision robotic stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatments.  **[1138723_20251008SF92852:0]** 
- The initiative addresses the projected **nearly 50 percent increase in new cancer cases in Australia from 2022 to 2045**, underscoring the need for innovative treatment options.  **[1138723_20251008SF92852:0]**

ACCURAY (ARAY)